Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004330 · ClinicalTrials.gov registry record · NA
Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks
A NA study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- NA
- Development phase
NCT00004330: Completed NA study, sponsored by National Center for Research Resources (NCRR).
NCT00004330 is a NA study that has completed, run by National Center for Research Resources (NCRR). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004330, a NA study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
OBJECTIVES: Assess whether chronic administration of gonadotropin-releasing hormone analogues is safe and effective for the prevention of cyclic attacks of acute porphyria in women.
Interventions
- DRUG luteinizing hormone-releasing factor
Trial Details
| Field | Value |
|---|---|
| Start Date | 1987-03 |
| Phase | NA |
What the finished NCT00004330 record still lists
NCT00004330 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which luteinizing hormone-releasing factor is the first listed.
NCT00004330 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004330 about?
NCT00004330 is a clinical study titled "Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks". OBJECTIVES: Assess whether chronic administration of gonadotropin-releasing hormone analogues is safe and effective for the prevention of cyclic attacks of acute porphyria in women.
What is the current status of trial NCT00004330?
This trial is currently completed. It is a NA study. The study started on 1987-03.
What interventions are being tested in trial NCT00004330?
The interventions under investigation include: luteinizing hormone-releasing factor (DRUG).
Who is sponsoring clinical trial NCT00004330?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia